about
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors.A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic ConstipationPlecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC miceTherapeutic applications of guanylate cyclase-C receptor agonists.Bioterrorism: a new frontier for drug discovery and development.Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.Therapeutically targeting guanylate cyclase-C: computational modeling of plecanatide, a uroguanylin analog.
P50
Q33441161-C789D0EF-48CD-4A61-B5AE-73AAA6A9F159Q33634439-78EA5BD9-83EB-4F5F-A4E0-453D15E414A3Q34551599-6CB503AA-4BED-44EC-B1B2-F8F437F487B9Q34583025-965EF7B6-DB5C-4963-B9E3-C3562E0F0647Q35199198-09BDFCF9-24AA-4394-AACD-0BC19757E288Q36254155-1E1AD7B0-D306-4583-8F6B-AA940E7C2E39Q40432382-8ECE3C71-F5DE-4D31-AECA-CD9D50ADABC7Q42293861-BB4E79C3-39D5-4EC7-9C67-6F65696546B2
P50
description
onderzoeker
@nl
name
Kunwar Shailubhai
@ast
Kunwar Shailubhai
@en
Kunwar Shailubhai
@es
Kunwar Shailubhai
@nl
Kunwar Shailubhai
@sl
type
label
Kunwar Shailubhai
@ast
Kunwar Shailubhai
@en
Kunwar Shailubhai
@es
Kunwar Shailubhai
@nl
Kunwar Shailubhai
@sl
prefLabel
Kunwar Shailubhai
@ast
Kunwar Shailubhai
@en
Kunwar Shailubhai
@es
Kunwar Shailubhai
@nl
Kunwar Shailubhai
@sl